Loading company…
MicroOptx develops minimally invasive devices to treat glaucoma.
Founded in 2014 and based in Minnesota, US, MicroOptx develops medical devices for glaucoma treatment. Its technology shunts aqueous humour from the front of the eye to its surface to lower intraocular pressure. In August 2019, the company raised USD 3 million in Series C funding from HBM Partners. Chris Pulling was CEO as of 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in